Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05476523 · ClinicalTrials.gov registry record
Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures
A clinical trial of Eye Movement, sponsored by NeuraLight.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT05476523: Recruiting study of Eye Movement, sponsored by NeuraLight.
NCT05476523 is a study of Eye Movement that is actively recruiting participants, run by NeuraLight. The registered enrollment target is 2,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05476523, a study of Eye Movement, is actively recruiting participants, sponsored by NeuraLight.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational prospective study in a cohort of healthy subjects who are enrolled using convenience and snowballing sampling. The aims of the study is to demonstrate the efficacy of using NeuraLight system to capture oculometric data from healthy participants and to validate the data capture of NeuraLight oculometric measurements as compared with a validated eye-tracker system in subjects who meet the inclusion criteria and who provide a signed Informed Consent.
Primary Outcome
Capturing \>50 different oculometric measures in \>95% of a cohort of up to 2000 subjects
Conditions Studied
Interventions
- OTHER NeuraLight
Study Locations (1)
Delaware
- NeuraLight - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2022-07-22 |
| Est. Completion | 2026-12-31 |
What NCT05476523 shows while recruiting
NCT05476523 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Eye Movement appearing as the primary indexed condition, and to 1 intervention - of which NeuraLight is the first listed.
NCT05476523 reports a single indexed study location in Delaware.
Frequently Asked Questions
What is clinical trial NCT05476523 about?
NCT05476523 is a clinical study titled "Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures". This is an observational prospective study in a cohort of healthy subjects who are enrolled using convenience and snowballing sampling. The aims of the study is to demonstrate the efficacy of using NeuraLight system to capture oculometric data from healthy participants and to validate the data captu...
What is the current status of trial NCT05476523?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2022-07-22. Estimated completion is 2026-12-31.
What conditions does trial NCT05476523 study?
This clinical trial studies the following conditions: Eye Movement.
What interventions are being tested in trial NCT05476523?
The interventions under investigation include: NeuraLight (OTHER).
Who is sponsoring clinical trial NCT05476523?
This trial is sponsored by NeuraLight, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05476523 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI